 | • レポートコード：MRC2303L128 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、239ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査資料によると、細胞表面マーカーの世界市場規模は2021年に660.37百万ドル、2022年に719.97百万ドルとなり、その後CAGR 9.20％で成長して2027年までに1,119.95百万ドルに到達する見通しです。本書では、世界の細胞表面マーカー市場について多面的に調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別分析（抗体、PCRアレイ）、ソース別分析（マウス、ラット）、細胞タイプ別分析（B細胞表面マーカー、単球細胞表面マーカー、NK細胞表面マーカー、T細胞表面マーカー）、エンドユーザー別分析（学術＆研究機関、病院＆臨床試験研究所、製薬＆バイオテクノロジー企業）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの項目をまとめています。なお、本書には、Abcam、Becton, Dickinson and Company、Bio-Rad Laboratories、Bio-Techne、Biolegend、Cell Signaling Technology、Danaher Corporation、F. Hoffman-La Roche、Genscript、Merk KGaA、Qiagen N.V.、Thermo Fisher Scientificなどの企業情報を掲載しています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の細胞表面マーカー市場規模：製品別 - 抗体の市場規模 - PCRアレイの市場規模 ・世界の細胞表面マーカー市場規模：ソース別 - マウスの市場規模 - ラットの市場規模 ・世界の細胞表面マーカー市場規模：細胞タイプ別 - B細胞表面マーカーの市場規模 - 単球細胞表面マーカーの市場規模 - NK細胞表面マーカーの市場規模 - T細胞表面マーカーの市場規模 ・世界の細胞表面マーカー市場規模：エンドユーザー別 - 学術＆研究機関における市場規模 - 病院＆臨床試験研究所における市場規模 - 製薬＆バイオテクノロジー企業における市場規模 ・世界の細胞表面マーカー市場規模：地域別 - 南北アメリカの細胞表面マーカー市場規模 アメリカの細胞表面マーカー市場規模 カナダの細胞表面マーカー市場規模 ブラジルの細胞表面マーカー市場規模 ... - アジア太平洋の細胞表面マーカー市場規模 日本の細胞表面マーカー市場規模 中国の細胞表面マーカー市場規模 インドの細胞表面マーカー市場規模 韓国の細胞表面マーカー市場規模 台湾の細胞表面マーカー市場規模 ... - ヨーロッパ/中東/アフリカの細胞表面マーカー市場規模 イギリスの細胞表面マーカー市場規模 ドイツの細胞表面マーカー市場規模 フランスの細胞表面マーカー市場規模 ロシアの細胞表面マーカー市場規模 ... - その他地域の細胞表面マーカー市場規模 ・競争状況 ・企業情報 |
The Global Cell Surface Markers Market size was estimated at USD 660.37 million in 2021 and expected to reach USD 719.97 million in 2022, and is projected to grow at a CAGR 9.20% to reach USD 1,119.95 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Cell Surface Markers to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Antibodies and Pcr Arrays.
Based on Source, the market was studied across Mice and Rats.
Based on Cell Type, the market was studied across B Cell Surface Markers, Monocyte Cell Surface Markers, NK Cell Surface Markers, and T Cell Surface Markers.
Based on Application, the market was studied across Clinical and Research. The Clinical is further studied across Immunodeficiency Diseases and Oncology. The Research is further studied across Drug Discovery, Immunology, and Stem Cell Research.
Based on End User, the market was studied across Academic & Research Institutes, Hospitals & Clinical Testing Laboratories, and Pharmaceutical & Biotechnology Companies.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Cell Surface Markers market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell Surface Markers Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell Surface Markers Market, including Abcam, Becton, Dickinson and Company, Bio-Rad Laboratories, Bio-Techne, Biolegend, Cell Signaling Technology, Danaher Corporation, F. Hoffman-La Roche, Genscript, Merk KGaA, Qiagen N.V., and Thermo Fisher Scientific.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Cell Surface Markers Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell Surface Markers Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell Surface Markers Market?
4. What is the competitive strategic window for opportunities in the Global Cell Surface Markers Market?
5. What are the technology trends and regulatory frameworks in the Global Cell Surface Markers Market?
6. What is the market share of the leading vendors in the Global Cell Surface Markers Market?
7. What modes and strategic moves are considered suitable for entering the Global Cell Surface Markers Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing automation in the laboratories
5.1.1.2. Rising need for adoption of in vitro diagnostics
5.1.1.3. Growing occurrence rate of cancer and other autoimmune diseases
5.1.2. Restraints
5.1.2.1. Disinclination for investment in sophisticated models
5.1.3. Opportunities
5.1.3.1. Growing investment in research and development to launch new drugs
5.1.3.2. Rising technological advancement in the healthcare sector
5.1.4. Challenges
5.1.4.1. Complexity and cost associated with instruments
5.2. Cumulative Impact of COVID-19
6. Cell Surface Markers Market, by Product
6.1. Introduction
6.2. Antibodies
6.3. Pcr Arrays
7. Cell Surface Markers Market, by Source
7.1. Introduction
7.2. Mice
7.3. Rats
8. Cell Surface Markers Market, by Cell Type
8.1. Introduction
8.2. B Cell Surface Markers
8.3. Monocyte Cell Surface Markers
8.4. NK Cell Surface Markers
8.5. T Cell Surface Markers
9. Cell Surface Markers Market, by Application
9.1. Introduction
9.2. Clinical
9.3.1. Immunodeficiency Diseases
9.3.2. Oncology
9.3. Research
9.4.1. Drug Discovery
9.4.2. Immunology
9.4.3. Stem Cell Research
10. Cell Surface Markers Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Hospitals & Clinical Testing Laboratories
10.4. Pharmaceutical & Biotechnology Companies
11. Americas Cell Surface Markers Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Cell Surface Markers Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Cell Surface Markers Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Abcam
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Becton, Dickinson and Company
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. Bio-Rad Laboratories
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Bio-Techne
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Biolegend
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Cell Signaling Technology
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. Danaher Corporation
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. F. Hoffman-La Roche
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. Genscript
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Merk KGaA
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. Qiagen N.V.
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. Thermo Fisher Scientific
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing